| Press Release - | Cat Allergy in Humans Market to Reach Valuation of USD 5.46 Billion by 2028 – Increasing Adoption Of Cats Drives the Market |
Vantage Market Research | 20 Jul 2022
Healthcare
Cat Allergy in Humans Market to Reach Valuation of USD 5.46 Billion by 2028 – Increasing Adoption Of Cats Drives the Market

In terms of revenue, the Global Cat Allergy in Humans Market is expected to reach USD 5.46 Billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 5.8% from 2022 to 2028.
The increasing adoption of cats is anticipated to augment the growth of the Cat Allergy in Humans Market during the forecast period. In addition, the rise in the incidence of allergic rhinitis and the expansion of government-funded healthcare programs to promote awareness of cat litter allergy in humans are driving the growth of the Cat Allergy in Humans Market.
Key Highlights from Report:
Market Dynamics:
Dead flakes of skin exposure trigger the main reason for pet allergy. Animals can cause pet allergy if they have fur on the body, but mainly pet allergy is associated with cats and dogs. There are many symptoms caused by inflammation of the nasal passage. Such as runny nose, itchy nose, sneezing, nasal congestion, cough, and swollen blue-colored skin under the eyes. These are some signs and symptoms experienced by humans.
It is estimated that globally around 10-20% of human adults are allergic to cats (a figure that has been increasing), that cat allergy among humans is second only to house dust mite as a cause of indoor respiratory allergy, and that around 20-30% of patients with respiratory allergy are allergic to cats.
A 2008 survey by the World Society for the Protection of Animals (WSPA) compared estimated owned pet dog and cat populations in 79 countries worldwide and found that in 26 (33%), the cat population was higher than the dog population. The data from WSPA also suggested that cat populations globally were growing faster than dog populations. Similarly, a Growth from Knowledge Survey published in 2016 found that in 8/22 (36%) countries surveyed, and there were a higher number of cat-owning households than dog-owning households.
North America held the most significant shares in 2021. The US had the largest share in this region for the Cat Allergy in Humans Market, owing to the high number of cat allergies reported in this region. In addition, technological development related to testing allergies is also expected to support the growth of the Cat Allergy in Humans Market.
About Vantage Market Research:
We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.
Healthcare
Cat Allergy in Humans Market to Reach Valuation of USD 5.46 Billion by 2028 – Increasing Adoption Of Cats Drives the Market
20 Jul 2022
Min Read
Access Full Report
Cat Allergy in Humans Market to Reach Valuation of USD 5.46 Billion by 2028 – Increasing Adoption Of Cats Drives the Market
This report by Vantage Market Research delivers comprehensive analysis of Somatostatin Analogs Market , focusing on Market Size, Share & Trends Analysis Report by Type (Octreotide, Lanreotide, Pasireotide) by Application (Acromegaly, Neuroendocrine Tumors (NETs), Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Request SampleRelated Reports
Latest Press Release
Contact
Toll Free Number+1 (877) 462-2282